This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.

This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.

A photosensitive coloring composition includes a magenta pigment having an average primary particle diameter of 50 nm or less, a polymerizable compound, a photopolymerization initiator, and an ultraviolet absorber, in which the magenta pigment has a maximum absorption wavelength in a range of 500 to 600 nm, the magenta pigment is Color Index Pigment Violet 19, and in a case where an absorbance of the maximum absorption wavelength is 1, a wavelength at which an absorbance is 0.5 is 450 nm or more on a side where a wavelength is shorter than the maximum absorption wavelength and is 650 nm or less on a side where a wavelength is longer than the maximum absorption wavelength.

A photosensitive coloring composition includes a magenta pigment having an average primary particle diameter of 50 nm or less, a polymerizable compound, a photopolymerization initiator, and an ultraviolet absorber, in which the magenta pigment has a maximum absorption wavelength in a range of 500 to 600 nm, the magenta pigment is Color Index Pigment Violet 19, and in a case where an absorbance of the maximum absorption wavelength is 1, a wavelength at which an absorbance is 0.5 is 450 nm or more on a side where a wavelength is shorter than the maximum absorption wavelength and is 650 nm or less on a side where a wavelength is longer than the maximum absorption wavelength.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

This invention relates to anti-microbial active particles, compositions and uses thereof for inhibiting bacterial growth on surfaces or devices. This invention further discloses methods of making such anti-microbial active particles.

This invention relates to anti-microbial active particles, compositions and uses thereof for inhibiting bacterial growth on surfaces or devices. This invention further discloses methods of making such anti-microbial active particles.

Disclosed are hydrophobic, acrylic materials having both high refractive index and a high Abbe number. The materials may have an internal wetting agent, are well suited for use as implantable ophthalmic devices, and have a refractive index which may be edited through application of energy. When used for an intraocular lens, the high refractive index allows for a thin lens which compresses to allow a small incision size.

Disclosed are hydrophobic, acrylic materials having both high refractive index and a high Abbe number. The materials may have an internal wetting agent, are well suited for use as implantable ophthalmic devices, and have a refractive index which may be edited through application of energy. When used for an intraocular lens, the high refractive index allows for a thin lens which compresses to allow a small incision size.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.